Richard A. Smith, M.D.
Richard A. Smith, M.D. is the medical director and founder of the Center for Neurologic Study and is also one of the founders of Coordinated Clinical Research. Since completing his neurology residency at Stanford University, Dr. Smith has been involved in both laboratory and clinical research resulting in publication in numerous medical and scientific journals, including the New England Journal of Medicine, Journal of the American Medical Association, Neurology, Annals of Neurology, Journal of Clinical Endocrinology and Metabolism, and many others. Dr Smith has edited two books, the first dealing with Interferon and the second with Amyotrophic Lateral Sclerosis. In addition to his many publications, Dr Smith has been issued numerous US patents based on discoveries made at CNS by Dr. Smith and his colleagues. These have resulted in the creation of Zenvia™ which is under development by Avanir Pharmaceutical Corporation. Currently Dr Smith is a Skaggs Clinical Scholar (Scripps Research Institute) and a Visiting Scholar at the University of California. His recent research focuses on the development of novel therapies directed toward the treatment of ALS and Huntington’s disease.
Back to Our Doctors
View Our Research Coordinators
Our Current Clinical Trials